Trial
NCT06834542
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Grit Biotechnology
Collaborators
—
Condition
Adult Gynecological Tumors
Intervention
Autologous tumor infiltrating lymphocyte injection（GT201）
Why stopped
The study was terminated from a business perspective.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-27